Operating Lease, Right-of-Use Asset of Revolution Medicines, Inc. from 31 Mar 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Revolution Medicines, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 31 Dec 2025.
  • Revolution Medicines, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $132,084,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Revolution Medicines, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $132,084,000 +$14,550,000 +12% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $134,450,000 +$60,112,000 +81% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $114,000,000 +$38,695,000 +51% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $115,777,000 +$39,584,000 +52% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $117,534,000 +$40,385,000 +52% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $74,338,000 +$21,216,000 +40% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $75,305,000 +$21,572,000 +40% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $76,193,000 +$21,891,000 +40% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $77,149,000 +$22,072,000 +40% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $53,122,000 -$3,137,000 -5.6% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $53,733,000 -$3,701,000 -6.4% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q1
Q1 2023 $54,302,000 -$4,268,000 -7.3% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $55,077,000 -$4,615,000 -7.7% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $56,259,000 +$31,025,000 +123% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $57,434,000 +$31,509,000 +122% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $58,570,000 +$31,875,000 +119% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $59,692,000 +$32,257,000 +118% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $25,234,000 -$2,960,000 -10% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $25,925,000 -$2,967,000 -10% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $26,695,000 +$18,227,000 +215% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $27,435,000 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $28,194,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $28,892,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $8,468,000 31 Mar 2020 10-Q 14 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.